Today, June 21, 2016, ExpreS2ion Biotech Holding AB and its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion Biotech”) announce that its fundamental S2 vector system patent, entitled “Improved Protein Expression System”, has issued in the U.S.A. with patent expiry August 16, 2032. This follows a recent notice of allowance for the patent in the Republic of Korea. The patent has also been granted in Japan, Australia and China, and has been validated in a number of EU countries following approval by the European Patent Office.

Read the whole press release (pdf)